200 related articles for article (PubMed ID: 35183359)
41. Genetic susceptibility to pancreatic cancer.
Klein AP
Mol Carcinog; 2012 Jan; 51(1):14-24. PubMed ID: 22162228
[TBL] [Abstract][Full Text] [Related]
42. Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes.
Chu D; Kohlmann W; Adler DG
JOP; 2010 May; 11(3):203-12. PubMed ID: 20442513
[TBL] [Abstract][Full Text] [Related]
43. Familial Pancreatic Cancer and the Future of Directed Screening.
Welinsky S; Lucas AL
Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
[TBL] [Abstract][Full Text] [Related]
44. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
45. Susceptibility genes and exocrine pancreatic cancer.
Suthers G
J Gastroenterol Hepatol; 2004 Sep; 19(9):1086. PubMed ID: 15304132
[No Abstract] [Full Text] [Related]
46. Inherited pancreatic cancer: improvements in our understanding of genetics and screening.
Rulyak SJ; Brentnall TA
Int J Biochem Cell Biol; 2004 Aug; 36(8):1386-92. PubMed ID: 15147717
[TBL] [Abstract][Full Text] [Related]
47. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
48. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.
Larghi A; Verna EC; Lecca PG; Costamagna G
Clin Cancer Res; 2009 Mar; 15(6):1907-14. PubMed ID: 19276278
[TBL] [Abstract][Full Text] [Related]
49. Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement.
Săftoiu A; Hassan C; Areia M; Bhutani MS; Bisschops R; Bories E; Cazacu IM; Dekker E; Deprez PH; Pereira SP; Senore C; Capocaccia R; Antonelli G; van Hooft J; Messmann H; Siersema PD; Dinis-Ribeiro M; Ponchon T
Endoscopy; 2020 Apr; 52(4):293-304. PubMed ID: 32052404
[TBL] [Abstract][Full Text] [Related]
50. Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics.
Verna EC; Hwang C; Stevens PD; Rotterdam H; Stavropoulos SN; Sy CD; Prince MA; Chung WK; Fine RL; Chabot JA; Frucht H
Clin Cancer Res; 2010 Oct; 16(20):5028-37. PubMed ID: 20876795
[TBL] [Abstract][Full Text] [Related]
51. Role of endoscopy in screening of early pancreatic cancer and bile duct cancer.
Tanaka K; Kida M
Dig Endosc; 2009 Jul; 21 Suppl 1():S97-S100. PubMed ID: 19691747
[TBL] [Abstract][Full Text] [Related]
52. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.
Vangala DB; Cauchin E; Balmaña J; Wyrwicz L; van Cutsem E; Güller U; Castells A; Carneiro F; Hammel P; Ducreux M; van Laethem JL; Matysiak-Budnik T; Schmiegel W
Eur J Cancer; 2018 Nov; 104():91-103. PubMed ID: 30342310
[TBL] [Abstract][Full Text] [Related]
53. Surveillance of patients with hereditary gastrointestinal cancer syndromes.
Moreira L; Castells A
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):923-935. PubMed ID: 27938787
[TBL] [Abstract][Full Text] [Related]
54. A cost analysis of a pancreatic cancer screening protocol in high-risk populations.
Bruenderman E; Martin RC
Am J Surg; 2015 Sep; 210(3):409-16. PubMed ID: 26003200
[TBL] [Abstract][Full Text] [Related]
55. Stool testing for the early detection of pancreatic cancer: rationale and current evidence.
Haug U; Wente MN; Seiler CM; Jesenofsky R; Brenner H
Expert Rev Mol Diagn; 2008 Nov; 8(6):753-9. PubMed ID: 18999925
[TBL] [Abstract][Full Text] [Related]
56. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families.
King E; Nehoray BM
Clin J Oncol Nurs; 2019 Dec; 23(6):579-582. PubMed ID: 31730603
[TBL] [Abstract][Full Text] [Related]
57. Updated risk factors to inform early pancreatic cancer screening and identify high risk patients.
Principe DR; Rana A
Cancer Lett; 2020 Aug; 485():56-65. PubMed ID: 32389710
[TBL] [Abstract][Full Text] [Related]
58. [Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group].
Szmola R; Farkas G; Hegyi P; Czakó L; Dubravcsik Z; Hritz I; Kelemen D; Lásztity N; Morvay Z; Oláh A; Párniczky A; Rubovszky G; Sahin-Tóth M; Szentkereszti Z; Szücs Á; Takács T; Tiszlavicz L; Pap Á;
Orv Hetil; 2015 Feb; 156(8):326-39. PubMed ID: 25662149
[TBL] [Abstract][Full Text] [Related]
59. Inherited predisposition to pancreatic cancer.
Hilfrank KJ; Rustgi SD; Kastrinos F
Semin Oncol; 2021 Feb; 48(1):2-9. PubMed ID: 33773812
[TBL] [Abstract][Full Text] [Related]
60. Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012.
Wada K; Takaori K; Traverso LW; Hruban RH; Furukawa T; Brentnall TA; Hatori T; Sano K; Takada T; Majima Y; Shimosegawa T
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):557-66. PubMed ID: 23604538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
